Our team has demonstrated that oxidative stress, triggered by high glucose, increases T14 peptide levels in vitro and reduces cell viability. The cyclic form of T14, NBP14, blocked these toxic effects, suggesting its potential as a therapeutic agent. These findings highlight that oxidative stress could activate T14 in the adult brain through AChE upregulation, contributing to neurodegeneration in Alzheimer’s disease.
LATEST NEWS
- CEO & Founder Baroness Susan Greenfield visits San Raffaele Hospital in Milan!
- Neuro-Bio featured in Corriere Salute – a health & wellbeing section of Corriere della Sera, one of Italy’s most established and widely read national newspapers!
- Our CSO Sara Garcia Rates & Project Development Manager, Bethany Watkinson, will be attending the MediWales (BioWales) event on Thursday 5th February
- Neuro-Bio’s CEO & Founder, Baroness Susan Greenfield is attending the “Inspire and Innovate with wise+ (Women in Innovation, Science & Engineering)” at the Novartis Basel Campus
- Neuro-bio hosts the Tenants lunch for Culham Campus!